Professor Ashley Dunn received his PhD from the University of Birmingham, UK, and undertook postdoctoral studies at Cold Spring Harbor Laboratory, USA and at the European Molecular Biology Laboratory, Heidelberg, Germany.
In 1982, he took up a position as Head of the Molecular Biology Program at the Melbourne Branch of the Ludwig Institute for Cancer Research. In 1984, Professor Dunn and colleagues molecularly cloned GM‐CSF, a cytokine currently used clinically to aid recovery of bone marrow in cancer patients following chemotherapy treatment. He was elected as a Fellow of the Australian Academy of Science in 1996, served as Associate Director of the Ludwig Institute until 2004 and is currently a Professorial Fellow of the Department of Surgery at the University of Melbourne.
Professor Dunn is currently a science consultant and serves on a number of scientific advisory boards in academia and the biotechnology sector.